Bioamber Inc (BIOAQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 14,943 | 8,273 | 2,172 | 1,543 | 2,665 |
| Cost of Goods | 22,324 | 13,667 | 2,613 | 6,044 | 2,689 |
| Gross Profit | -7,381 | -5,394 | -441 | -4,501 | -24 |
| Operating Expenses | 102,956 | 24,903 | 38,701 | 30,748 | 41,845 |
| Operating Income | -110,013 | -29,630 | -38,529 | -35,205 | -41,180 |
| Other Income | 7,908 | 1,285 | -2,646 | -12,069 | 13,356 |
| Pre-tax Income | -102,105 | -28,345 | -41,174 | -47,274 | -27,824 |
| Income Tax | 82 | 26 | -4 | 75 | 103 |
| Net Income Continuous | -102,187 | -28,371 | -41,171 | -47,349 | -27,926 |
| Minority Interests | -4,035 | -5,893 | -3,945 | -875 | -574 |
| Net Income | $-98,152 | $-22,478 | $-37,226 | $-46,474 | $-27,353 |
| EPS Basic Total Ops | -2.34 | -0.78 | -1.52 | -2.32 | -1.75 |
| EPS Basic Continuous Ops | -2.44 | -0.99 | -1.68 | -2.37 | -1.79 |
| EPS Diluted Total Ops | -2.34 | -0.78 | -1.52 | -2.32 | -1.75 |
| EPS Diluted Continuous Ops | -2.44 | -0.99 | -1.68 | -2.37 | -1.79 |
| EPS Diluted Before Non-Recurring Items | -0.70 | -1.07 | -1.55 | -1.74 | -2.14 |
| EBITDA(a) | $-102,280 | $-21,475 | $-36,371 | $-34,653 | $-39,775 |